Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma

Bone Marrow Transplantation

Volumn 22, Issue 2, 1998, Pages 161-166

  Von Neuhoff, N ^a,b   Dreger, P ^a   Suttorp, M ^a   Marget, M ^a   Kell, S ^a   Schmitz, N ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Second Department of Medicine   (Germany)

Author keywords

CDRIII; Lymphoma; Molecular monitoring; PCR; Stem cell transplantation; t(14; 18)

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; ARTICLE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; FOLLICULAR LYMPHOMA; GEL ELECTROPHORESIS; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0031902688     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701300     Document Type: Article

References (21)

1. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New Engl J Med 1991; 325: 1525-1533.
2. Johnson PWM, Price CGA, Smith T et al Detection of cells bearing the t(14:18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 1994; 12: 798-805.
3. Freedman AS, Gribben JG, Neuberg D et al. High-dose therapy and autolgous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996; 88: 2780-2786.
4. Colombat P, Donadio D, Fouillard L et al. Value of autologous bone marrow transplantation in follicular lymphoma: a France autogreffe retrospective study of 42 patients. Bone Marrow Transplant 1994; 13: 157-162.
5. Hardingham JE, Kotasek D, Sage RE et al Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 1993; 11: 15-20.
6. Zwicky CS, Maddocks AB, Andersen N et al. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood 1996; 88: 3314-3322.
7. Corradini P, Astolfi M, Cherasco C et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's tyrnphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. Blood 1997; 89: 724-731.
8. Hardingham JE, Kotasek D, Sage RE et al. Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1995; 13: 1073-1079.
9. Lee MS, Chang KS, Cabanillas F et al. Detection of minimal residual cells carrying the t(14:18) by DNA sequence aniplification. Science 1987; 237: 175-178.
10. Ngan BY, Nourse J, Cleary ML. Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in folliculur lymphomas. Blood 1989; 73: 1759-1762.
11. Turner GE; Ross FM; Krajewski AS. Detection of t(14:18) in British follicular lymphoma using cytogenetics. Southern blotting and the polymerase chain reaction. Br J Haematol 1995; 89: 223-225.
12. Stewart AK, Schwartz RS. Immunoglobin V regions and the B cell. Blood 1994; 83: 1717-1730.
13. Schroeder HW, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994: 15: 288-294.
14. Linke B, Pyttich J, Tiemann M et al Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas leukemias. Leukemia 1995; 9: 840-847.
15. Suttorp M, von Neuhoff N, Tiemann M et al. Precast commercial polyacrylamide gels for separation of DNA amplificates by temperature gel eleclrophoresis: application to clonalily analysis of lymphomas. Electrophoresis 1996; 17: 672-677.
16. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
17. Stansfield A, Diebold J, Kapanci Y et al. Updated Kiel classification for lymphoma. Lancet 1988; i: 292-296.
18. Schmitz N, Linen DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357.
19. Suttorp M, Dreger P, Verhey D et al. Molecular methods as valuable tools for assessing the purging efficacy of peripheral blood stem cell harvests contaminated by defined numbers of tumor cells. Br J Haematol 1994; 87 (Suppl. 1): 139 (Abstr.).
20. Trainor KJ, Brisco MJ Story CJ et al. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990: 75: 2220-2222.
21. Kneba M, Eick S, Herbst H et al. Frequency and structure of t(14;18) major breakpoint regions in non Hodgkin lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res 1991; 51: 3243-3250.